other material
confidence high
sentiment neutral
materiality 0.25
Mirum reports immaterial SVB exposure (<1% of cash)
Mirum Pharmaceuticals, Inc.
- Less than 1% of cash, equivalents, restricted cash and investments held at SVB.
- SVB placed under FDIC receivership; company believes exposure is immaterial.
- May experience delays in transferring funds due to banking system disruption.
- No other financial impact disclosed as of March 10, 2023.